Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair

被引:35
|
作者
Sharma, Aruna [1 ]
Menon, Preeti [1 ]
Muresanu, Dafin F. [2 ,3 ]
Ozkizilcik, Asya [4 ]
Tian, Z. Ryan [5 ]
Lafuente, Jose V. [6 ,7 ]
Sharma, Hari S. [1 ]
机构
[1] Uppsala Univ, Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, SE-75185 Uppsala, Sweden
[2] Univ Med Pharm, Dept Clin Neurosci, Cluj Napoca, Romania
[3] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania
[4] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA
[5] Univ Arkansas, Chem & Biochem, Fayetteville, AR 72701 USA
[6] Univ Basque Country, UPV EHU, Dept Neurosci, Lab Clin & Expt Neurosci LaNCE, Leioa, Bizkaia, Spain
[7] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
Alzheimer disease; blood-brain barrier; brain edema; central nervous system injury; ischemic insult; nanowired drug delivery; neuroproetction; Parkinson disease; traumatic brain injury; SPINAL-CORD-INJURY; WHOLE-BODY HYPERTHERMIA; MESENCHYMAL STEM-CELLS; ACUTE METHAMPHETAMINE INTOXICATION; ENHANCES NEUROPROTECTIVE EFFICACY; SIO2 NANOPARTICLES EXPOSURE; IRON-OXIDE NANOPARTICLES; ACUTE HEAT EXPOSURE; EDEMA FORMATION; SLEEP-DEPRIVATION;
D O I
10.2174/1871527315666160819123059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) is a physiological regulator of transport of essential items from blood to brain for the maintenance of homeostasis of the central nervous system (CNS) within narrow limits. The BBB is also responsible for export of harmful or metabolic products from brain to blood to keep the CNS fluid microenvironment healthy. However, noxious insults to the brain caused by trauma, ischemia or environmental/chemical toxins alter the BBB function to small as well as large molecules e.g., proteins. When proteins enter the CNS fluid microenvironment, development of brain edema occurs due to altered osmotic balance between blood and brain. On the other hand, almost all neurodegenerative diseases and traumatic insults to the CNS and subsequent BBB dysfunction lead to edema formation and cell injury. To treat these brain disorders suitable drug therapy reaching their brain targets is needed. However, due to edema formation or only a focal disruption of the BBB e.g., around brain tumors, many drugs are unable to reach their CNS targets in sufficient quantity. This results in poor therapeutic outcome. Thus, new technology such as nanodelivery is needed for drugs to reach their CNS targets and be effective. In this review, use of nanowires as a possible novel tool to enhance drug delivery into the CNS in various disease models is discussed based on our investigations. These data show that nanowired delivery of drugs may have superior neuroprotective ability to treat several CNS diseases effectively indicating their role in future therapeutic strategies.
引用
收藏
页码:1092 / 1117
页数:26
相关论文
共 50 条
  • [1] The blood-brain barrier and drug delivery in the central nervous system
    Loch-Neckel, Gecioni
    Koepp, Janice
    [J]. REVISTA DE NEUROLOGIA, 2010, 51 (03) : 165 - 174
  • [2] Central nervous system delivery of molecules across the blood-brain barrier
    Gosselet, Fabien
    Loiola, Rodrigo Azevedo
    Roig, Anna
    Rosell, Anna
    Culot, Maxime
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2021, 144
  • [3] The blood-brain barrier and nasal drug delivery to the central nervous system
    Miyake, Marcel Menon
    Bleier, Benjamin S.
    [J]. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2015, 29 (02) : 124 - 127
  • [4] The role of blood-brain barrier in drug delivery to the central nervous system
    Deli, MA
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 : S14 - S15
  • [5] Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
    Mikitsh, John L.
    Chacko, Ann-Marie
    [J]. PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 11 - 24
  • [6] Drug Delivery across the Blood-Brain Barrier
    Khawli, Leslie A.
    Prabhu, Saileta
    [J]. MOLECULAR PHARMACEUTICS, 2013, 10 (05) : 1471 - 1472
  • [7] Drug delivery across the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Baehr, CH
    Miller, DS
    Fricker, G
    [J]. CURRENT NANOSCIENCE, 2005, 1 (03) : 203 - 209
  • [8] Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier
    Wang, Xiang
    Yin, Yue
    Zhou, Huaijuan
    Chi, Bowen
    Guan, Ling
    Li, Pei
    Li, Jinhua
    Wang, Yilong
    [J]. EXPLORATION, 2024,
  • [9] Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system
    Kim, Jinhwan
    Ahn, Song Ih
    Kim, YongTae
    [J]. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2019, 73 : 8 - 18
  • [10] Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system
    Crawford, Lindsey
    Rosch, Justin
    Putnam, David
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 251 - 266